血浆神经丝轻链与非痴呆老年人脑小血管病负荷的纵向关联
研究基于阿尔茨海默病神经影像学倡议数据库496名非痴呆老年人,其中387人(78.0%)完成纵向测量,评估血浆NfL与脑小血管病(CSVD)负荷的横断面及纵向关联。结果显示血浆NfL较高与中重度CSVD负荷相关,NfL变化率较高可预测CSVD负荷进展。
要点
- 血浆NfL升高与中重度CSVD负荷、微出血、腔隙性梗死及中重度白质高信号相关。
- NfL变化率较高可预测CSVD负荷、白质高信号及腔隙性梗死的进展。
- 血浆NfL可作为无创生物标志物辅助MRI评估CSVD严重程度与风险。
核心结论
- 血浆NfL水平是有价值的无创生物标志物,可补充MRI扫描并可能反映CSVD负荷的严重程度。
- 血浆NfL水平较高倾向于代表CSVD风险增加,NfL水平的动态升高可能预测CSVD的更大进展。
研究设计与样本
- 研究纳入阿尔茨海默病神经影像学倡议数据库中496名非痴呆参与者,均接受血浆NfL测量与3.0-Tesla脑MRI。
- 387名(78.0%)参与者接受了纵向测量。
- 测量指标包括脑微出血数目、腔隙性梗死、白质高信号体积及Fazekas评分,采用多变量校正模型评估横断面与纵向关联。
主要发现
- 基线时中重度CSVD负荷组血浆NfL为45.2±16.0 pg/mL,高于无负荷组的34.3±15.1 pg/mL(OR=1.71[95%CI,1.24-2.35])。
- NfL与脑微出血存在正相关(OR=1.29[95%CI,1.01-1.64])。
- NfL与腔隙性梗死存在正相关(OR=1.43[95%CI,1.06-1.93])。
- NfL与中重度白质高信号存在正相关(OR=1.67[95%CI,1.24-2.25])。
- 纵向来看,NfL变化率较高可预测CSVD负荷更多进展(OR=1.38[95%CI,1.08-1.76])、白质高信号进展(OR=1.41[95%CI,1.10-1.79])及腔隙性梗死进展(OR=1.99[95%CI,1.42-2.77])。
临床怎么用
- 在非痴呆老年人中,可考虑将血浆NfL作为辅助MRI评估CSVD负荷严重程度的无创监测指标。
- 动态监测血浆NfL升高可能有助于识别CSVD进展风险较高的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Neurofilament light chain (NfL) is a promising predictive biomarker of active axonal injury and neuronal degeneration diseases. We aimed to evaluate if an increase in plasma NfL levels could play a monitoring role in the progression of cerebral small vessel disease (CSVD) among the nondemented elders, which are highly prevalent in elderly individuals and associated with an increased risk of stroke and dementia. METHODS: The study included 496 nondemented participants from the Alzheimer disease neuroimaging initiative database. All participants underwent plasma NfL measurements and 3.0-Tesla magnetic resonance imaging of the brain; 387 (78.0%) underwent longitudinal measurements. The number of cerebral microbleeds, lacunar infarcts, and volumetric white matter hyperintensities, as well as Fazekas scores, were measured. Cross-sectional and longitudinal associations between CSVD burden and NfL levels were evaluated using multivariable-adjusted models. RESULTS: Plasma NfL was higher in the moderate-severe CSVD burden group (45.2±16.0 pg/mL) than in the nonburden group (34.3±15.1 pg/mL; odds ratio [OR]=1.71 [95% CI, 1.24-2.35]) at baseline. NfL was positively associated with the presence of cerebral microbleeds (OR=1.29 [95% CI, 1.01-1.64]), lacunar infarcts (OR=1.43 [95% CI, 1.06-1.93]), and moderate-severe white matter hyperintensities (OR=1.67 [95% CI, 1.24-2.25]). Longitudinally, a higher change rate of NfL could predict more progression of CSVD burden (OR=1.38 [95% CI, 1.08-1.76]), white matter hyperintensities (OR=1.41 [95% CI, 1.10-1.79]), and lacunar infarcts (OR=1.99 [95% CI, 1.42-2.77]). CONCLUSIONS: Plasma NfL level is a valuable noninvasive biomarker that supplements magnetic resonance imaging scans and possibly reflects the severity of CSVD burden. Furthermore, high plasma NfL levels tend to represent an increased CSVD risk, and dynamic increases in NfL levels might predict a greater progression of CSVD.
引用
- Qu Y, Tan CC, Shen XN, et al. Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study. Stroke. 2021. PMID: 33517704. doi:10.1161/STROKEAHA.120.030302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。